Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rapamune and Resistance Training in Aged Muscle
NCT05414292Recruiting
- Sponsor
- University of Nottingham
- Start
- Aug 2021
- Primary completion
- May 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of sirolimus in Sarcopenia (2 arms), sponsored by University of Nottingham. Primary endpoint: Change in muscle mass from baseline at 5 weeks. Started Aug 2021; status: recruiting.
02
Drugs
sirolimus
03
Conditions
Sarcopenia
Beyond the preview
Go deeper on NCT05414292.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05414292.